Cairo Pharmaceuticals and Chemical Industries (CAI:CPCI), also known as Kahira Pharmaceuticals & Chemical Industries Co., is an Egypt-based company engaged in the manufacture and trade of pharmaceutical products for human and veterinary use, cosmetics, and pesticides. The Company has production agreement licenses from international pharmaceutical companies, such as Abbot International Ltd, Eli Lilly S.A., Ravizza, Eaton Laboratories Inc. and Searle Pharm. It produces medical drugs and chemical preparations in the forms of tablets, capsules, syrups, suspensions, ampoules, eye and nasal drops, and suppositories. The Company is a member of the Holding Company for Pharmaceuticals Chemicals and Medical Appliances. It exports its products to the African Asian and European markets.
Cairo Pharmaceuticals And Chemical Industries
CAI:CPCI ISIN:EGS38391C016
News
Prime Asset Management Completes Quarterly Review of the 324 Stocks Traded on the Egyptian Stock Exchange.
###
2,336 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 25) (Since Published: 2336)